Camel's Milk as a Safe Alternative in Cow's Milk Allergy

This study is currently recruiting participants.

Verified August 2012 by Meir Medical Center

Sponsor:

Information provided by (Responsible Party):

Meir Medical Center

ClinicalTrials.gov Identifier:

NCT01223885

First received: October 10, 2010

Last updated: August 9, 2012

Last verified: August 2012

History of Changes

Purpose

By performing a challenge with camel's milk in patients who are allergic to cow's milk, the investigators will examine if camel's milk is a safe alternative for these patients.

Condition	Intervention
Cow's Milk Allergy	Dietary Supplement: Camel's milk

Study Type:	Interventional
Study Design:	Endpoint Classification: Safety Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Allergy

U.S. FDA Resources

Further study details as provided by Meir Medical Center:

Primary Outcome Measures:

Development of allergic symptoms after graded oral challenge with camel's milk [ Time Frame: 3 hours follow-up after completion of the challenge ] [ Designated as safety issue: Yes ]

Estimated Enrollment:	30
Study Start Date:	December 2010
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Camel's milk, Cow's milk allergy	Dietary Supplement: Camel's milk Patients with proved cow's milk allergy who have negative prick skin tests to came's milk will be administered gradually increased doses of pasteurized camel's milk at 30 minute intervals

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Proved cow"s milk allergy

Exclusion Criteria:

Pregnant women

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01223885

Contacts

Contact: Arnon Goldberg, MD

972-9-7472717

arnong@clalit.org.il

Locations

Israel
Allergy Unit, Meir Medical Center	Recruiting
Kfar-Saba, Israel, 44281
Contact: Arnon Goldberg, MD 972-9-7472717 arnong@clalit.org.il
Principal Investigator: Arnon Goldberg, MD

Sponsors and Collaborators

Meir Medical Center

More Information

No publications provided

Responsible Party:	Meir Medical Center
ClinicalTrials.gov Identifier:	NCT01223885 History of Changes
Other Study ID Numbers:	CM-MK-2
Study First Received:	October 10, 2010
Last Updated:	August 9, 2012
Health Authority:	Israel: Ministry of Health

Additional relevant MeSH terms:

Hypersensitivity
Milk Hypersensitivity
Immune System Diseases
Food Hypersensitivity
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on May 19, 2013

To Top